CTRI/2012/12/003249招募中3 期
Phase III Randomized trial of image guided intensity modulated radiotherapy (IG-IMRT) and conventional radiotherapy for late toxicity reduction after postoperative adjuvant radiotherapy in CA Cervix - PARCER
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age >18 to 65 years
- •2.Histopathological diagnosis of carcinoma cervix with post operative intermediate or high risk feature
- •3.Planned for Wertheimâ??s hysterectomy or has already undergone Wertheimâ??s hysterectomy or has undergone simple hysterectomy with no evidence of residual nodes on MRI PET imaging+/- confirmatory nodal biopsy
- •4.No evidence of para aortic nodal metastasis
排除标准
- •1.History of multiple previous abdominal surgery placing patient at baseline high risk of bowel toxicity or any other medical condition with baseline bowel movement disorder
- •2.Rectal polyps or extensive hemorrhoids
研究者
相似试验
尚未招募
3 期
Radiation therapy with Image Guided Intensity Modulated Radiotherapy and standard radiation therapy after surgery in cervical cancer patients.CTRI/2010/091/002959il240
已完成
不适用
Phase I/II clinical trial of stereotactic body radiotherapy in patients with cervical cancer who are unsuitable for intracavitary brachytherapyterine cervical cancerJPRN-UMIN000036845Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital21
进行中（未招募）
1 期
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung CancerRecurrent Lung Non-Small Cell CarcinomaStage II Non-Small Cell Lung Cancer AJCC v7Stage IIA Non-Small Cell Lung Carcinoma AJCC v7Stage IIB Non-Small Cell Lung Carcinoma AJCC v7Stage IIIA Non-Small Cell Lung Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7NCT01629498M.D. Anderson Cancer Center146
已完成
3 期
Tomotherapy vs Conventional Radiation for Adjuvant Pelvic RT in Ca CervixCancer CervixNCT01279135Tata Memorial Hospital300
进行中（未招募）
1 期
An Imaging Sub-Study of the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated With Vitamin D and Calcium - The Imaging Sub-study for the Fracture TrialMedDRA version: 9.1Level: LLTClassification code 10017082Term: Fracture due to osteoporosisMedDRA version: 9.1Level: LLTClassification code 10031285Term: Osteoporosis postmenopausalPostmenopausal OsteoporosisEUCTR2008-004578-42-DKMerck & Co. Inc.400